TimeScale Financial’s Bristol-Myers Squibb BMY Stock Holding History

TimeScale Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$30.1K	Sell	470 -811	-63%	-$54.4K	0.01%	258
2023 Q1	$88.8K	Buy	1,281 +640	+100%	+$45.1K	0.02%	160
2022 Q4	$45.6K	Hold	641	–	–	0.01%	167
2022 Q3	$46K	Hold	641	–	–	0.01%	166
2022 Q2	$49K	Sell	641 -1,001	-61%	-$76.2K	0.01%	164
2022 Q1	$120K	Buy	1,642 +51	+3%	+$3.42K	0.03%	115
2021 Q4	$99K	Buy	1,591 +1	+0.1%	+$59	0.02%	132
2021 Q3	$94K	Sell	1,590 -1	-0.1%	-$66	0.02%	133
2021 Q2	$106K	Sell	1,591 -95	-6%	-$6.2K	0.03%	124
2021 Q1	$106K	Buy	1,686 +4	+0.2%	+$249	0.03%	119
2020 Q4	$104K	Sell	1,682 -802	-32%	-$49.3K	0.03%	107
2020 Q3	$149K	Sell	2,484 -223	-8%	-$13.4K	0.04%	80
2020 Q2	$160K	Hold	2,707	–	–	0.05%	74
2020 Q1	$150K	Sell	2,707 -168	-6%	-$10.3K	0.05%	69
2019 Q4	$184K	Buy	2,875 +903	+46%	+$51.7K	0.06%	88
2019 Q3	$100K	Hold	1,972	–	–	0.03%	118
2019 Q2	$89K	Buy	+1,972	New	+$91.9K	0.03%	133

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TimeScale Financial's BMY Position: Q2 2023 in Review

TimeScale Financial reduced its Bristol-Myers Squibb (BMY) stake by 63% in Q2 2023, selling an estimated $54.4K and leaving 470 shares worth $30.1K. The position accounts for 0.01% of the portfolio, ranked #258.

TimeScale Financial first reported a position in BMY in Q2 2019 and has held it in 17 quarters since. The position peaked at $184K in Q4 2019. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

TimeScale Financial held 470 shares of Bristol-Myers Squibb worth $30.1K as of Q2 2023.
TimeScale Financial sold 811 Bristol-Myers Squibb shares in Q2 2023, an estimated $54.4K.
Bristol-Myers Squibb made up 0.01% of TimeScale Financial's portfolio in Q2 2023, its #258 holding.
TimeScale Financial first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's Bristol-Myers Squibb position peaked at $184K in Q4 2019.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.